Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase III double blind, placebo controlled study of donepezil in irradiated brain tumor patients

		Phase:		Phase 3

		Treatment ID#:		1901 2007-0532

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed radiation-induced cognitive impairment

		Last Updated:		04/03/2009

		Tumor Types:		Any Malignant Brain Tumor Metastatic Brain Tumor


		Comments:		Donepezil has demonstrated beneficial effects on cognitive, behavioral and functional symptoms. Patients must not have any other therapy planned for 30 weeks after study entry.

		Treatment Type:		Less-Toxics

		Contact:		Jan Esenwein Program Coordinator, Brain Tumor Program MD Anderson Cancer Center 1515 Holcombe Blvd Houston, TX 77030- USA Phone: (713)745-2264 Fax: (713)794-4999 E-mail: jesenwei@mdanderson.org Website: www.mdanderson.org/diseases/braincancer/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By